Skip to main content
. 2021 Oct 4;15:736891. doi: 10.3389/fnins.2021.736891

FIGURE 4.

FIGURE 4

Predictability of genetic profiles and WHO tumor grade in glioma patients. ROC analyses performed for OEF and vascular metrics in order to assess the contrast ability to predict (A) IDH mutation status in LGG (IDH1–R132H mutation vs. wild type), (B) MGMT promoter methylation status in GBM (methylated vs. unmethylated), (C) RTK subgroup in a subset of patients with NGS, and (D) WHO tumor grade (GBM vs. LGG).